Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy.

MLA

Crombie, Jennifer L., et al. “Prognostic Value of Early Positron Emission Tomography in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy.” Haematologica, vol. 108, no. 12, Dec. 2023, pp. 3433–37. EBSCOhost, https://doi.org/10.3324/haematol.2022.282345.

APA

Crombie, J. L., Jacobson, C. A., Redd, R., Shouse, G., Herrera, A. F., Chow, V. A., Gauthier, J., Mullane, E., Cahill, K., Kline, J., Romancik, J., Cohen, J. B., Saucier, A., Houot, R., Armand, P., & Hess, B. (2023). Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy. Haematologica, 108(12), 3433–3437. https://doi.org/10.3324/haematol.2022.282345

Chicago

Crombie, Jennifer L, Caron A Jacobson, Robert Redd, Geoffrey Shouse, Alex F Herrera, Victor A Chow, Jordan Gauthier, et al. 2023. “Prognostic Value of Early Positron Emission Tomography in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy.” Haematologica 108 (12): 3433–37. doi:10.3324/haematol.2022.282345.